Iqram King is an Executive Director and Global Biostatistics and Clinical Strategy Leader with extensive experience in the pharmaceutical industry. They currently lead global statistical and clinical analytics teams at Pfizer, focusing on precision medicine strategies for respiratory diseases. Previously, they have held prominent roles at organizations such as Roche, Bristol Myers Squibb, and Genentech, where they managed cross-functional teams and directed initiatives in data science and regulatory strategy. Iqram is advanced in their education, pursuing a Ph.D. and a Master's degree in Statistics from Rice University and Texas A&M University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices